Latest Data & Signals Issued

Signal Type Signal Value Data
Score 0.000 60 days ( 0 % )
Last Price $0.401 0 %
High/ Low $0.401 - $0.401 0%
Chg 7 Days N/A $0.401 $0.401
Chg 30 Days N/A $0.401 $0.401
Chg 12 mos -96.30 % $10.83 $0.401
Trend - 3 mos N/A Width: 0 %
Trend - 12 mos -33.11 % Width: 299.68 %
Pred. range - 3 mos N/A - N/A -100.00 % - -100.00 %
Pred. range - 12 mos N/A - $15.69 -100.00 % - 3,813.80 %
Short MA avg 3 mos Sell Nov 30, -1 - N/A days
Long MA avg 3 mos Sell Nov 30, -1 - N/A days
Short/Long MA avg 3 mos Sell Nov 30, -1 - N/A days
Short MA avg 12 mos Buy Nov 17, 2023 - 90 days
Long MA avg 12 mos Sell Oct 19, 2023 - 111 days
Short/Long MA avg 12 mos Sell Nov 03, 2023 - 100 days
Pivot Short Buy Mar 27, 2024 - 2 days
Bollinger Sell Nov 30, -1 - N/A days
MACD N/A No Dates Stored For This Signal
Click to get the best stock tips daily for free!

About Axcella Health Inc.

Axcella Health. Axcella Health Inc. operates as a clinical stage biotechnology company in the United States. The company treats complex diseases and enhances health using endogenous metabolic modulator compositions. Its lead product candidates include AXA1665, which is in Phase 2 clinical trial for the reduction in risk of overt hepatic encephalopathy recurrence; and AXA1125 that is in Phase 2b clinical trial for treating non-alcoholic steatohepatitis, as well a... AXLA Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT